Alborz Bulk

What Alborz Bulk does

Alborz Bulk Pharmaceutical Company is an Iranian Active Pharmaceutical Ingredient (API) manufacturer founded in 1380 Iranian calendar (approximately 2001-2002 CE) and headquartered in Tehran, with production operations based in Kaveh Industrial Town. The company operates GMP-certified manufacturing facilities and holds ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications, producing a portfolio of 38 pharmaceutical APIs spanning three therapeutic categories: general medicines (including cardiovascular agents such as Atorvastatin Calcium, Losartan Potassium, Rosuvastatin Calcium and Metoprolol variants; CNS drugs including Gabapentin, Citalopram, Escitalopram, Sertraline, Fluvoxamine Maleate and Dapoxetine; NSAIDs such as Naproxen; and miscellaneous APIs), steroid drugs (Betamethasone, Dexamethasone, Prednisolone, Triamcinolone, Cyproterone Acetate, Oxymetholone), and antibiotics (Cefixime, Azithromycin, Ciprofloxacin Hydrochloride). Recent launches include Ciprofloxacin and Fluvoxamine Maleate APIs.

The company is a publicly listed entity on Iran's Fara Bours over-the-counter exchange under the symbol دبالک (D.BALK), filing periodic reports through the Codal system and publishing audited financial statements for each fiscal period. Alborz Bulk sells APIs directly to downstream pharmaceutical manufacturers through an internal sales department ([email protected], [email protected]), operating as a B2B supplier with quote-based pricing. No public pricing or customer-level revenue breakdown is disclosed. The stated strategic positioning emphasizes national pharmaceutical self-sufficiency, continuous product portfolio expansion, and a stated vision to rank among the top three API manufacturers in Iran by Iranian calendar year 1407 (approximately 2028 CE).

Revenue mechanics rely on bulk API sales to domestic Iranian pharmaceutical manufacturers, with implied strategic intent to expand into regional and international markets. The company carries an affiliation with Barakat Pharmaceutical Group (گروه دارویی برکت) via its related-website listing, indicating a corporate ecosystem relationship. Recent corporate actions include a 150 billion Iranian rial capital increase approved by the shareholder assembly in 1402 (approximately 2023-2024 CE) and receipt of the highest corporate governance compliance score from the Farabourse Organization in 1403.

Name

Alborz Bulk

Legal name

Alborz Bulk Pharmaceutical Company (شرکت تولید مواد اولیه دارویی البرز بالک)

Website

https://alborzbulk.com

Company type

Public

Operating status

Operating

Headcount range

11–50 employees

Short description

Alborz Bulk is a Tehran-based, Fara Bours-listed Iranian manufacturer of Active Pharmaceutical Ingredients (APIs), producing 38 GMP-certified generic APIs across general, steroid, and antibiotic categories for domestic pharmaceutical manufacturers, with stated ambition to rank among Iran's top three API producers by 1407.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (API) Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

akta.pro secondary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical API manufacturing
• Generic drug substances
• Steroid API production
• Antibiotic API supply

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (API) Sales: Manufacturing and sale of Active Pharmaceutical Ingredients to pharmaceutical companies for drug formulation. The company produces generic APIs across three categories: General medicines, Steroid drugs, and Antibiotics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Alborz Bulk manufactures and supplies Active Pharmaceutical Ingredients (APIs) in bulk to pharmaceutical manufacturers for use as raw materials in finished drug formulation. Its portfolio spans approximately 38 generic APIs organized into General medicines (cardiovasculars, CNS agents, NSAIDs, anesthetics, preservatives), Steroid drugs, and Antibiotics, produced under GMP certification at its Kaveh Industrial Town factory. The company sells B2B to domestic Iranian drug manufacturers and pursues regional export expansion.

Product overview

Alborz Bulk is a pharmaceutical company specializing in the production and supply of Active Pharmaceutical Ingredients (APIs). The company's product portfolio consists of three main categories: General APIs (including cardiovascular drugs like Atorvastatin Calcium, Losartan Potassium, Rosuvastatin Calcium, and Metoprolol variants; neurological/psychiatric drugs like Gabapentin, Sertraline Hydrochloride, Citalopram-HBr, Escitalopram Oxalate, Fluvoxamine Maleate, and Dapoxetine; pain management drugs like Naproxen and Lidocaine Base; and other therapeutic drugs), Steroid APIs (including Betamethasone Sodium Phosphate, Betamethasone Valerate, Dexamethasone Sodium Phosphate, Triamcinolone Acetonide, Cyproterone Acetate, Oxymetholone, and Prednisolone), and Antibiotic APIs (including Cefixime, Azithromycin, and Ciprofloxacin Hydrochloride). The company operates under GMP certification and supplies pharmaceutical manufacturers in domestic and international markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Atorvastatin Calcium A statin medication used for lowering cholesterol, CAS Registry Number 134523-03-8; bulk Active Pharmaceutical Ingredient sold B2B to pharmaceutical manufacturers for finished dosage formulation.
• Naproxen Nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation, CAS Registry Number 22204-53-1; bulk API supplied to pharmaceutical manufacturers.
• Lidocaine Base Local anesthetic agent used for numbness, CAS Registry Number 137-58-6; bulk API supplied to pharmaceutical manufacturers.
• Dextromethorphan Hydrobromide Cough suppressant acting on the medullary cough center in the brain, CAS Registry Number 125-69-9; bulk API supplied to pharmaceutical manufacturers.
• Prednisolone Anti-inflammatory corticosteroid medication, CAS Registry Number 50-24-8; bulk steroid API supplied to pharmaceutical manufacturers.
• Aprepitant Antiemetic medication used for prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV); bulk API supplied to pharmaceutical manufacturers.
• Carbamazepine Anticonvulsant used to control grand mal and psychomotor or focal seizures, CAS Registry Number 298-46-4; bulk API supplied to pharmaceutical manufacturers.
• Citalopram-HBr Antidepressant medication belonging to the selective serotonin reuptake inhibitor (SSRI) class; bulk API supplied to pharmaceutical manufacturers.
• Dapoxetine Treatment for premature ejaculation (PE) in men, CAS Registry Number 129938-20-1; bulk API supplied to pharmaceutical manufacturers.
• Escitalopram Oxalate Antidepressant used for treatment of depression and anxiety disorders; bulk API supplied to pharmaceutical manufacturers.
• Fluvoxamine Maleate Antidepressant medication; bulk API supplied to pharmaceutical manufacturers. Launched as part of Alborz Bulk's 1402 portfolio expansion alongside Ciprofloxacin.
• Gabapentin Anticonvulsant used for epilepsy treatment and pain management, CAS Registry Number 219861-08-2; bulk API supplied to pharmaceutical manufacturers.
• Loratadine Antihistamine for treatment of symptoms of seasonal allergic rhinitis, CAS Registry Number 79794-75-5; bulk API supplied to pharmaceutical manufacturers.
• Losartan Potassium Angiotensin receptor blocker for high blood pressure treatment and heart disease treatment, CAS Registry Number 124750-99-8; bulk API supplied to pharmaceutical manufacturers.
• Rosuvastatin Calcium Statin medication used for lowering cholesterol, CAS Registry Number 147098-20-2; bulk API supplied to pharmaceutical manufacturers.
• Sitagliptin Phosphate Monohydrate DPP-4 inhibitor medication for type 2 diabetes treatment, CAS Registry Number 654671-77-9; bulk API supplied to pharmaceutical manufacturers.
• Sertraline Hydrochloride Antidepressant medication, CAS Registry Number 79559-97-0; bulk API supplied to pharmaceutical manufacturers.
• Metoprolol Succinate Cardio-selective beta-blocker for acute myocardial infarction, heart failure, angina pectoris and hypertension, CAS Registry Number 98418-47-4; bulk API supplied to pharmaceutical manufacturers.
• Metoprolol Tartrate Beta-blocker medication for cardiovascular conditions, CAS Registry Number 56392-17-7; bulk API supplied to pharmaceutical manufacturers.
• Methyl Paraben Pharmaceutical and cosmetic preservative, CAS Registry Number 99-76-3; bulk API supplied to pharmaceutical manufacturers.
• Propyl Paraben Pharmaceutical and cosmetic preservative, CAS Registry Number 94-13-3; bulk API supplied to pharmaceutical manufacturers.
• Betamethasone Sodium Phosphate Anti-inflammatory corticosteroid medication, CAS Registry Number 151-73-5; bulk steroid API supplied to pharmaceutical manufacturers.
• Cefixime Cephalosporin antibiotic used to treat bacterial infections, CAS Registry Number 79350-37-1; bulk antibiotic API supplied to pharmaceutical manufacturers.
• Azithromycin Macrolide antibiotic for treatment of bacterial infections; bulk antibiotic API supplied to pharmaceutical manufacturers.
• Ciprofloxacin Hydrochloride Fluoroquinolone antibiotic used to treat bacterial infections, CAS Registry Number 86393-32-0; bulk antibiotic API supplied to pharmaceutical manufacturers. Launched as part of Alborz Bulk's 1402 portfolio expansion alongside Fluvoxamine Maleate.
• Betamethasone Valerate Anti-inflammatory corticosteroid for joint, tendon, and skin conditions, CAS Registry Number 2152-44-5; bulk steroid API supplied to pharmaceutical manufacturers.
• Cyproterone Acetate Antiandrogen medication used for treatment of hypersexuality in males and severe acne in females, CAS Registry Number 427-51-0; bulk steroid API supplied to pharmaceutical manufacturers.
• Oxymetholone Anabolic steroid for treatment of osteoporosis and anemia, CAS Registry Number 434-07-1; bulk steroid API supplied to pharmaceutical manufacturers.
• Dexamethasone Sodium Phosphate Anti-inflammatory corticosteroid, CAS Registry Number 2392-39-4; bulk steroid API supplied to pharmaceutical manufacturers.
• Triamcinolone Acetonide Anti-inflammatory corticosteroid medication, CAS Registry Number 76-25-5; bulk steroid API supplied to pharmaceutical manufacturers.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Barakat Pharmaceutical Group (گروه دارویی برکت)minorOthersRelated company within the pharmaceutical ecosystem. Listed as a related website link on Alborz Bulk's website, indicating a corporate or group relationship.

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Laurus Labs: Indian API-focused manufacturer specializing in small-molecule APIs across therapeutic categories including cardiovascular and anti-infectives. Directly comparable product portfolio and target customer base (generic drug formulators) to Alborz Bulk.
• Sobhan Oncology: Iranian pharmaceutical company with API manufacturing capabilities supplying the domestic market. Comparable in business model as a domestic Iranian API and specialty drug producer competing for the same regulated customer base.
• Divi's Laboratories: India-based pure-play small-molecule API manufacturer with extensive generic API portfolio across cardiovascular, anti-infective, and CNS categories. Highly comparable to Alborz Bulk in product category and therapeutic coverage, but at vastly larger scale.
• Barakat Pharmaceutical Group: Iranian pharmaceutical holding group listed as a related entity on Alborz Bulk's website. Operates in adjacent formulation and distribution within the Iranian state-affiliated pharma ecosystem, making it the closest domestic peer and potential offtake channel.
• Darou Pakhsh Pharmaceutical Manufacturing Company: One of Iran's largest pharmaceutical manufacturers with API and finished dosage form capabilities, serving the same domestic formulary customers as Alborz Bulk. Directly comparable as a vertically integrated Iranian pharma-API competitor.
• TPICO (Tehran Pharmaceutical Investment Company): Iranian pharmaceutical holding with API and finished drug operations listed on Tehran Stock Exchange. Comparable as a domestic publicly listed pharma producer targeting the same national self-sufficiency agenda.
• CinnaGen: Iranian biotech and pharmaceutical company producing APIs and finished dosage forms for the domestic and regional market. Comparable as a private-to-publicly-listed Iranian pharmaceutical manufacturer focused on national self-sufficiency.

Broad incumbents

• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with an active API business (Teva API) producing small-molecule generics including cardiovascular, CNS, and anti-infective categories. Comparable as a broad incumbent with overlapping product portfolio, but operating globally with different scale and regulatory access.
• Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with vertically integrated API and finished formulation operations across many of the same therapeutic categories as Alborz Bulk (statins, SSRIs, cephalosporins, macrolides). Comparable as a global generic-API incumbent at much larger scale.
• Dr. Reddy's Laboratories: Global Indian generic pharmaceutical company with substantial API manufacturing operations serving regulated and semi-regulated markets. Comparable as a broader incumbent with overlapping product categories, though larger and more diversified than Alborz Bulk.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/alborz-bulk-pharmaceutical-co.

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alborz Bulk